The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Lactacystin and clasto-Lactacystin β-Lactone Modify Multiple Proteasome β-Subunits and Inhibit Intracellular Protein Degradation and Major Histocompatibility Complex Class I Antigen Presentation
Open accessAbstract
The antibiotic lactacystin was reported to covalently modify beta-subunit X of the mammalian 20 S proteasome and inhibit several of its peptidase activities. However, we demonstrate that [3H]lactacystin treatment modifies all the proteasome's catalytic beta-subunits. Lactacystin and its more potent derivative beta-lactone irreversibly inhibit protein breakdown and the chymotryptic, tryptic, and peptidylglutamyl activities of purified 20 S and 26 S particles, although at different rates. Exposure to these agents for 1 to 2 h reduced the degradation of short- and long-lived proteins in four different mammalian cell lines. Unlike peptide aldehyde inhibitors, lactacystin and the beta-lactone do not inhibit lysosomal degradation of an endocytosed protein. These agents block class I antigen presentation of a model protein, ovalbumin (synthesized endogenously or loaded exogenously), but do not affect presentation of the peptide epitope SIINFEKL, which does not require proteolysis for presentation. Generation of most peptides required for formation of stable class I heterodimers is also inhibited. Because these agents inhibited protein breakdown and antigen presentation similarly in interferon-gamma-treated cells (where proteasomes contain LMP2 and LMP7 subunits in place of X and Y), all beta-subunits must be affected similarly. These findings confirm our prior conclusions that proteasomes catalyze the bulk of protein breakdown in mammalian cells and generate the majority of class I-bound epitopes for immune recognition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Self-citationSTRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Self-citationSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Fuerst, T. R., Niles, E. G., Studier, F. W., & Moss, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8122 · Cited by 2,089
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
Self-citationCrystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
A 26 S protease subunit that binds ubiquitin conjugates.
Deveraux, Q., Ustrell, V., Pickart, C., & Rechsteiner, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37244-7 · Cited by 761
Proteasome from Thermoplasma acidophilum : a Threonine Protease
Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R., & Baumeister, W. (1995) · Science · doi:10.1126/science.7725107 · Cited by 634
Cited by
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
Voges, D., Zwickl, P., & Baumeister, W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.1015 · Cited by 1,608
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Self-citationImpact of Natural Products on Developing New Anti-Cancer Agents
Cragg, G. M., Grothaus, P. G., & Newman, D. J. (2009) · Chemical Reviews · doi:10.1021/cr900019j · Cited by 1,302
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Self-citationIrreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
Rock, K. L., & Goldberg, A. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.739 · Cited by 921
Self-citationEpoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes
Kisselev, A. F., Akopian, T. N., Woo, K. M., & Goldberg, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3363 · Cited by 573
Self-citationProteasome Inhibition As a Novel Therapeutic Target in Human Cancer
Rajkumar, S. V., Richardson, P. G., Hideshima, T., & Anderson, K. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.030 · Cited by 569
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology · doi:10.1002/ana.20186 · Cited by 548
An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides
Saric, T., Chang, S.-C., Hattori, A., York, I. A., Markant, S., Rock, K. L., Tsujimoto, M., & Goldberg, A. L. (2002) · Nature Immunology · doi:10.1038/ni859 · Cited by 528
Self-citationProteasome Inhibitors: An Expanding Army Attacking a Unique Target
Kisselev, A. F., van der Linden, W. A., & Overkleeft, H. S. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.003 · Cited by 527
Cross‐presentation: underlying mechanisms and role in immune surveillance
Rock, K. L., & Shen, L. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00301.x · Cited by 451
Self-citationBogyo, M., McMaster, J. S., Gaczynska, M., Tortorella, D., Goldberg, A. L., & Ploegh, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6629 · Cited by 447
Self-citationThe ubiquitin‐proteasome pathway and proteasome inhibitors
Myung, J., Kim, K. B., & Crews, C. M. (2001) · Medicinal Research Reviews · doi:10.1002/med.1009 · Cited by 446
Kisselev, A. F., Callard, A., & Goldberg, A. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509043200 · Cited by 416
Self-citationLactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
Self-citation20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
Shen, L., Sigal, L. J., Boes, M., & Rock, K. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.004 · Cited by 391
Self-citationOn the Dynamics of TCR:CD3 Complex Cell Surface Expression and Downmodulation
Liu, H., Rhodes, M., Wiest, D. L., & Vignali, D. A. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)00066-2 · Cited by 374
Shanely, R. A., Zergeroglu, M. A., Lennon, S. L., Sugiura, T., Yimlamai, T., Enns, D., Belcastro, A., & Powers, S. K. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200202-088oc · Cited by 348
Goldberg, A. L., Cascio, P., Saric, T., & Rock, K. L. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00098-6 · Cited by 345
Self-citationProtein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
Self-citationRole of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins
Jackson, S., Harwood, C., Thomas, M., Banks, L., & Storey, A. (2000) · Genes & Development · doi:10.1101/gad.182100 · Cited by 319
Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome
Lin, L., DeMartino, G. N., & Greene, W. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81409-9 · Cited by 312
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
Impairment of proteasome structure and function in aging
Carrard, G., Bulteau, A.-L., Petropoulos, I., & Friguet, B. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00085-7 · Cited by 301
Beninga, J., Rock, K. L., & Goldberg, A. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18734 · Cited by 296
Self-citationKisselev, A. F., Akopian, T. N., Castillo, V., & Goldberg, A. L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80341-x · Cited by 292
Self-citationTanoka, K., & Kasahara, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01195.x · Cited by 282
High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors.
Alvarez, J., Montero, M., & Garcia-Sancho, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49767-6 · Cited by 281
Proteasome inhibition causes nigral degeneration with inclusion bodies in rats
McNaught, K. S. P., Bj??rklund, L. M., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2002) · Neuroreport · doi:10.1097/00001756-200208070-00018 · Cited by 274
A proteolytic system that compensates for loss of proteasome function
Glas, R., Bogyo, M., McMaster, J. S., Gaczynska, M., & Ploegh, H. L. (1998) · Nature · doi:10.1038/33443 · Cited by 270
Self-citationA Role for the Proteasome in the Light Response of the Timeless Clock Protein
Naidoo, N., Song, W., Hunter-Ensor, M., & Sehgal, A. (1999) · Science · doi:10.1126/science.285.5434.1737 · Cited by 269
The ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264
Craiu, A., Akopian, T., Goldberg, A., & Rock, K. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10850 · Cited by 264
Self-citationAltered proteasome structure, function, and oxidation in aged muscle.
Ferrington, D. A., Husom, A. D., & Thompson, L. V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2578fje · Cited by 259
Dick, T. P., Nussbaum, A. K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilholz, W., Stevanović, S., Wolf, D. H., Huber, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25637 · Cited by 260
Gil, J., Alcamí, J., & Esteban, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4653 · Cited by 199
“Although several parameters were unaffected in our virus-cell system after treatment with both drugs and, additionally, the use of other IFN-induced apoptosis-triggering enzymes, such as RNase L, served as a control, the cellular functions other than NF-kB activity (58) could be altered by inhibiting the proteasome (…”
BackgroundGeneralized brain and skin proteasome inhibition in Huntington’s disease
Seo, H., Sonntag, K., & Isacson, O. (2004) · Annals of Neurology · doi:10.1002/ana.20207 · Cited by 188
Chain, D. G., Casadio, A., Schacher, S., Hegde, A. N., Valbrun, M., Yamamoto, N., Goldberg, A. L., Bartsch, D., Kandel, E. R., & Schwartz, J. H. (1999) · Neuron · doi:10.1016/s0896-6273(00)80686-8 · Cited by 186
Self-citationKessler, B. M., Tortorella, D., Altun, M., Kisselev, A. F., Fiebiger, E., Hekking, B. G., Ploegh, H. L., & Overkleeft, H. S. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00069-2 · Cited by 163
FUERTES, G., DE LLANO, J. J. M., VILLARROYA, A., RIVETT, A. J., & KNECHT, E. (2003) · Biochemical Journal · doi:10.1042/bj20030282 · Cited by 149
Artinian, J., McGauran, A. T., De Jaeger, X., Mouledous, L., Frances, B., & Roullet, P. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06262.x · Cited by 145
“As LAC causes irreversible inhibition of protein breakdown (Craiu et al., 1997), injection 1 h before the known onset of this second wave of protein synthesis allowed us to cover the possibility of degradation occurring slightly before synthesis whilst maintaining inhibition throughout the second…”
BackgroundMethodInfluentialProteasomal activity in brain differs between species and brain regions and changes with age.
Zeng, B.-Y., Medhurst, A. D., Jackson, M., Rose, S., & Jenner, P. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.008 · Cited by 113
A novel mechanism for the regulation of amyloid precursor protein metabolism
Chen, Q., Kimura, H., & Schubert, D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110151 · Cited by 63
Døskeland, A. P., & Flatmark, T. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02808.x · Cited by 53
Metadata
- Authors
- Craiu, A., Gaczynska, M., Akopian, T., Gramm, C. F., Fenteany, G., Goldberg, A. L., & Rock, K. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-05
- Volume
- 272
- Issue
- 20
- Pages
- 13437-13445
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044005280
- Cited by
- 382
- References
- 47
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.